A Vannini

Summary

Country: Italy

Publications

  1. pmc Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    A Vannini
    Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, and Azienda Ospedaliero Universitaria S Orsola Malpighi, Bologna, Italy
    Ann Rheum Dis 66:511-6. 2007
  2. ncbi request reprint Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis
    M Fusconi
    Department of Internal Medicine, Azienda Ospedaliera S Orsola Malpighi, Bologna, Italy
    Aliment Pharmacol Ther 22:951-5. 2005

Collaborators

Detail Information

Publications2

  1. pmc Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    A Vannini
    Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, and Azienda Ospedaliero Universitaria S Orsola Malpighi, Bologna, Italy
    Ann Rheum Dis 66:511-6. 2007
    ..Recently, in a large group of patients with AIH-1 without clear rheumatoid arthritis overlap, a relatively high percentage (9%) of anti-CCP2 positivity was scored...
  2. ncbi request reprint Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis
    M Fusconi
    Department of Internal Medicine, Azienda Ospedaliera S Orsola Malpighi, Bologna, Italy
    Aliment Pharmacol Ther 22:951-5. 2005
    ..Recently, antibodies against cyclic citrullinated peptide have been validated as specific diagnostic and prognostic markers of rheumatoid arthritis...